TITLE

BIOTECHNOLOGY AND THE ANTHRAX LETTERS:

AUTHOR(S)
Herring, Benjamin L.
PUB. DATE
July 2009
SOURCE
Infonomics;Jul/Aug2009, Vol. 23 Issue 4, p4
SOURCE TYPE
Trade Publication
DOC. TYPE
Editorial
ABSTRACT
The author reflects on the link between the Enterprise Content Management (ECM) and biotechnology in the U.S. He states that the ECM has an important role in the biotechnology industry. He adds that allowing private companies to use technologies and giving them grants may exploit scientific information. He notes that biotechnology can also be used for evil and cited the case of the anthrax powder sent through mail that killed people. He concludes that effective ECM helps in solving tragedy.
ACCESSION #
43638054

 

Related Articles

  • Study to assess needs of biotech research here. Stacklin, Jeff // Crain's Cleveland Business;01/31/2000, Vol. 21 Issue 5, p20 

    Reports that Columbus, Ohio-based Edison BioTechnology Center commissioned Jonathan Murray to conduct the second phase of the study aimed at developing a consensus among existing biotechnological and biomedical firms on what is necessary for the industry to grow. Factors that might encourage...

  • Give a Dog a Clone. Bostrom, Johan // Bio-IT World;Jun2005, Vol. 4 Issue 6, p28 

    Highlights the aim of Genetic Savings & Clone, biotechnology company based in Sausalito, California, to clone pets such as dog and cats. Main investor in the company; Information on the cloning technology of the company; Background of the company.

  • Corporate development in biotechnology in 2005. Williams, Alan // Journal of Commercial Biotechnology;Apr2005, Vol. 11 Issue 3, p239 

    In 1998 the author produced two papers which argued that consolidation was a necessary activity for biotechnology companies to consider more. Three years later a further consideration of the subject was published. Corporate developments in biotechnology in the first decade of the 21st century...

  • GMO watch: Growth of biotech products slows. Uhland, Vicky // Natural Foods Merchandiser;Mar2005, Vol. 26 Issue 3, p23 

    Reports on biotechnology companies' slowed production of genetically modified (GM) crops. Factors that contributed to the biotech slowdown; GM crops supporters' arguments in support of genetically modified crops; Countries where GM products is a hot issue; Steps that can be taken to improve the...

  • Improving the Science of Taste. Mason, Annah // Equities;Mar2008, Vol. 56 Issue 2, p94 

    The article features Redpoint Bio Corporation, a biotech firm using sensory science to better recognize the markers behind human taste. It notes that it consists of several programs focused on identifying novel taste enhancers, which could be used to change the taste of a wide range of products....

  • THE BREADTH OF BIOLOGICAL THREATS IS MUCH BROADER THAN COMMONLY THOUGHT AND WILL CONTINUE TO EXPAND. Choffnes, Eileen R.; Lemon, Stanley M.; Relman, David A. // Bulletin of the Atomic Scientists;Sep/Oct2006, Vol. 62 Issue 5, p26 

    The article focuses on biological technological advancement in the world of science. It is said that the manipulation of genetic material was made possible through the discovery of the structured DNA in 1953. It was followed then by the recombinant technology two decades later. Such discovery...

  • INDIA'S LATEST WINNER? Radhakrishna, T. // Siliconindia;Aug2001, Vol. 5 Issue 8, p76 

    Features the biotechnology industries of India. Key players in the sector; Intellectual property issues relevant to the sector; Market prospects and opportunities.

  • Connecting product innovation management and marketing. Pitt, Leyland; McCarthy, Ian // Journal of Commercial Biotechnology;Jul2008, Vol. 14 Issue 3, p197 

    The article discusses various reports published within the issue including one by Nic Terblanche on the number of market opportunities for biotechnology firms and another by Pierre Berthon and colleagues on the complexity of biotechnology firms and the turbulent level of their environment.

  • The biobusiness. Paul, Paula // New Mexico Business Journal;Aug/Sep99, Vol. 23 Issue 7, p14 

    Discusses the growth of New Mexico's biotechnology, biomedicine and biopharmaceuticals industries. Recruitment of industry clusters; Formation of the New Mexico Biotechnology and Biomedical Association (NMBBA) in 1994; Economic impact of the bioscience industry; Technology Ventures Corp.'s...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics